295 related articles for article (PubMed ID: 19157947)
21. Invasive fungal infections in patients with cancer in the Intensive Care Unit.
Sipsas NV; Kontoyiannis DP
Int J Antimicrob Agents; 2012 Jun; 39(6):464-71. PubMed ID: 22337064
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of (1 → 3)-β-D-glucan in bronchoalveolar lavage fluid for invasive fungal disease: A meta-analysis.
Shi XY; Liu Y; Gu XM; Hao SY; Wang YH; Yan D; Jiang SJ
Respir Med; 2016 Aug; 117():48-53. PubMed ID: 27492513
[TBL] [Abstract][Full Text] [Related]
23. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index.
Posteraro B; De Pascale G; Tumbarello M; Torelli R; Pennisi MA; Bello G; Maviglia R; Fadda G; Sanguinetti M; Antonelli M
Crit Care; 2011; 15(5):R249. PubMed ID: 22018278
[TBL] [Abstract][Full Text] [Related]
24. Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections.
Badiee P; Kordbacheh P; Alborzi A; Malekhoseini S; Zeini F; Mirhendi H; Mahmoodi M
Liver Transpl; 2007 Jul; 13(7):1011-6. PubMed ID: 17600362
[TBL] [Abstract][Full Text] [Related]
25. Comparable Serum and Plasma 1,3-β-d-Glucan Values Obtained Using the Wako β-Glucan Test in Patients with Probable or Proven Fungal Diseases.
De Carolis E; Marchionni F; Torelli R; Posteraro P; De Pascale G; Carelli S; Sanguinetti M; Posteraro B
J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30842228
[No Abstract] [Full Text] [Related]
26. Measuring (1,3)-β-D-glucan in tracheal aspirate, bronchoalveolar lavage fluid, and serum for detection of suspected Candida pneumonia in immunocompromised and critically ill patients: a prospective observational study.
Su KC; Chou KT; Hsiao YH; Tseng CM; Su VY; Lee YC; Perng DW; Kou YR
BMC Infect Dis; 2017 Apr; 17(1):252. PubMed ID: 28390391
[TBL] [Abstract][Full Text] [Related]
27. [The effect of albumin on (1, 3)-β-D-glucan for diagnosis of invasive fungal infections].
Han S; Su X; Zhao R; Fang K
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Aug; 27(8):672-6. PubMed ID: 26255017
[TBL] [Abstract][Full Text] [Related]
28. High Levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease.
Mularoni A; Furfaro E; Faraci M; Franceschi A; Mezzano P; Bandettini R; Viscoli C; Castagnola E
Clin Vaccine Immunol; 2010 May; 17(5):882-3. PubMed ID: 20335432
[TBL] [Abstract][Full Text] [Related]
29. Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients.
Digby J; Kalbfleisch J; Glenn A; Larsen A; Browder W; Williams D
Clin Diagn Lab Immunol; 2003 Sep; 10(5):882-5. PubMed ID: 12965921
[TBL] [Abstract][Full Text] [Related]
30. β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study.
Hanson KE; Pfeiffer CD; Lease ED; Balch AH; Zaas AK; Perfect JR; Alexander BD
PLoS One; 2012; 7(8):e42282. PubMed ID: 22879929
[TBL] [Abstract][Full Text] [Related]
31. Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
Persat F; Ranque S; Derouin F; Michel-Nguyen A; Picot S; Sulahian A
J Clin Microbiol; 2008 Mar; 46(3):1009-13. PubMed ID: 18160456
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
Pickering JW; Sant HW; Bowles CA; Roberts WL; Woods GL
J Clin Microbiol; 2005 Dec; 43(12):5957-62. PubMed ID: 16333082
[TBL] [Abstract][Full Text] [Related]
33. Plasma (1-->3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis.
Miyazaki T; Kohno S; Mitsutake K; Maesaki S; Tanaka K; Ishikawa N; Hara K
J Clin Microbiol; 1995 Dec; 33(12):3115-8. PubMed ID: 8586684
[TBL] [Abstract][Full Text] [Related]
34. [The performance of (1, 3)-beta-D-glucan and Aspergillus galactomannan measurement for early diagnosis of invasive aspergillosis in patients with hematological diseases].
Horiguchi Y
Kansenshogaku Zasshi; 2004 Jul; 78(7):566-73. PubMed ID: 15359888
[TBL] [Abstract][Full Text] [Related]
35. Significance of serum β-D-glucan levels in recipients of living donor liver transplantation.
Yamanouchi K; Takatsuki M; Hidaka M; Soyama A; Kanematsu T; Eguchi S
J Hepatobiliary Pancreat Sci; 2011 May; 18(3):432-5. PubMed ID: 21120672
[TBL] [Abstract][Full Text] [Related]
36. Preemptive treatment of fungal infection based on plasma (1 --> 3)beta-D-glucan levels after liver transplantation.
Akamatsu N; Sugawara Y; Kaneko J; Tamura S; Makuuchi M
Infection; 2007 Oct; 35(5):346-51. PubMed ID: 17885729
[TBL] [Abstract][Full Text] [Related]
37. Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.
Ostrosky-Zeichner L; Alexander BD; Kett DH; Vazquez J; Pappas PG; Saeki F; Ketchum PA; Wingard J; Schiff R; Tamura H; Finkelman MA; Rex JH
Clin Infect Dis; 2005 Sep; 41(5):654-9. PubMed ID: 16080087
[TBL] [Abstract][Full Text] [Related]
38. Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study.
De Vlieger G; Lagrou K; Maertens J; Verbeken E; Meersseman W; Van Wijngaerden E
J Clin Microbiol; 2011 Nov; 49(11):3783-7. PubMed ID: 21880959
[TBL] [Abstract][Full Text] [Related]
39. Detection of (1→3)-β-D-glucan in same-day urine and serum samples obtained from patients with haematological malignancies.
Raggam RB; Fischbach LM; Prattes J; Duettmann W; Eigl S; Reischies F; Wölfler A; Rabensteiner J; Prueller F; Krause R; Hoenigl M
Mycoses; 2015 Jul; 58(7):394-8. PubMed ID: 25959065
[TBL] [Abstract][Full Text] [Related]
40. [Risk factors of invasive fungal infections in patients admitted to non- hematological oncology department and pediatric intensive care unit].
Zhao CS; Zhao SY; Liu G; Xi-Wei X
Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):598-601. PubMed ID: 24225291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
